Verition Fund Management
ONC

Verition Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

Verition Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-882
Closed -$262K – 2621
2026
Q1 		$262K Buy
+882
New +$285K ﹤0.01% 1837
2025
Q3 		– Sell
-10,208
Closed -$2.47M – 4051
2025
Q2 		$2.47M Sell
10,208
-8,520
-45% -$2.09M 0.01% 1764
2025
Q1 		$5.1M Buy
+18,728
New +$4.38M 0.02% 822
2024
Q4 		– Sell
-1,250
Closed -$281K – 3575
2024
Q3 		$281K Buy
+1,250
New +$225K ﹤0.01% 2687

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Verition Fund Management's ONC Position: Q2 2026 in Review

Verition Fund Management sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 882 shares — an estimated $262K sold.

Verition Fund Management first reported a position in ONC in Q3 2024 and held it in 4 quarters. The position peaked at $5.1M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Verition Fund Management reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 882 BeOne Medicines Ltd shares in Q2 2026, an estimated $262K.
  • Verition Fund Management first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 4 quarters.
  • Verition Fund Management's BeOne Medicines Ltd position peaked at $5.1M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.